Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Portugal’s INFARMED cleared Tilray’s Cantanhede EU-GMP facility to run microbiological, chemical, physical quality tests in-house. Move brings batch-release testing off third parties, aiming to cut costs, shorten timelines, accelerate product releases into regulated markets. Disclaimer: This news brief was created by P
Tilray Medical secured INFARMED clearance for on-site microbiological and chemical/physical quality testing at its EU-GMP Cantanhede facility. Move brings critical batch-release testing in-house, speeding product release across regulated medical cannabis markets. Shift reduces reliance on third-party labs, lowering rel
Approval allows Tilray Medical to conduct EU-GMP quality testing in-house, supporting product release across regulated global markets.